In collaboration with:

   efpia  MIT NEWDIGS logo combined

Royal College of Physicians, London, October 21st, 2014

A gathering of the world’s thought leaders in medicine’s adaptive pathways to patients (MAPPs).

Topics Include:

  • How can Europe proceed in the implementation of new development pathways and evidence generation to improve the access of needed new therapies to patients?
  • What are the current best practices, successes, and opportunities for the integration of patient data and analytics to improve patient outcomes and identify new medicines?
  • How can IMI2’s efforts and programmes under Horizon 2020 help European patients and healthcare providers?

Building on the EMA’s pilot project in adaptive pathways and the UK Government’s Support of a breakthrough designation, IMI, NewDigs and EFPIA will host this international conference to outline research and innovation in adaptive clinical pathways and patient data usage.


edward-abrahams2 ifty Mohammad-Al-Ubaydl
Edward Abrahams,
Personalized Medicine Coalition
Ifty Ahmed,
Pow Health
Mohammad Al-Ubaydli,
Patients Know Best®
James-sq andrea-beyer richard-barker
James Anderson,
Director of EU Industry & External Partnerships,
Andrea Beyer,
Benefit Risk Assessment
Richard Barker,
jack Finn-Børlum-Kristensen Helmut_Brand
Jack Bowman,
Handle my Health
Finn Børlum Kristensen,
Executive Director,
Helmut Brand,
International Forum Gastein
wendy-currie Hans-Georg_Eichler
Wendy Currie,
Editor in Chief,
Health Policy & Technology
Audencia, France
John Crawford,
Healthcare Industry Leader,
IBM Europe
Hans-Georg Eichler,
Senior Medical Officer,
European Medicines Agency
esserman_laura2  gary  george_freeman_portrait2
Laura Esserman,
Breast Cancer Center Director (I-Spy),
University of California San Francisco
Gary Finnegan,
Journalist, Editor
and Author
George Freeman,
Parliamentary Under Secretary of
State for Life Sciences,
UK Government
13849 Sarah-Garner  michel_goldman
Pat Furlong,
Founding President and CEO,
Parent Project Muscular Dystrophy
Sarah Garner,
Associate Director, Research and Development,
National Institutes of Clinical Excellence
Michel Goldman,
Executive Director,
Jeremy-Haigh joel-haspel2  adam-heathfield
Jeremy Haigh,
European Chief Operating Officer, Research & Development
Amgen Ltd.
Joel Haspel,
Director Strategy & Business
Development EMEA,
Oracle Health Sciences
Adam Heathfield,
Senior Director, Global Health and Value Innovation Center,
 ryan_hohman  Alastair-Kent-new  Faraz Photo
Ryan Hohman,
Managing Director, Policy & Public Affairs,
Friends of Cancer Research US
Alastair Kent,
Genetic Alliance UK
Faraz Kermani,
Senior Editor Europe,
Elsevier – The Pink Sheet
yannlecam3  sandrine-merreaud  jillianoderkirk
Yann Le Cam,
Sandrine Marreaud,
Head of Medical and Pharmacovigilance Department,
Jillian Oderkirk,
Senior Analyst, Health Division,
bettina_ryll  Duane  Cornelius_Schmaltz-sq
Bettina Ryll,
Melanoma Patient Network Europe
Duane Schulhtess,
Managing Director,
Vital Transformation
Dr Cornelius Schmaltz,
Deputy Head of Unit of the Fighting Infectious Diseases and Global
Epidemics unit, European Commission
Nathalie_small-sq  paolo-siviero2  olga_solomon
Nathalie Seigneuret,
Senior Scientific Project Manager,
Innovative Medicines Initiative (IMI)
Paolo Daniele Siviero,
Head of Office Pharmaceutical Policy,
Italian Medicines Agency
Olga Solomon,
Deputy Head of Unit,
DG Health and Consumers,
Medicinal products, authorisations – ema (D5), European Commission
sir_richard_thompson  richardT1  Trusheim rectangle crop
Sir Richard Thompson,
Immediate Past President,
Royal College of Physicians
Richard Torbett,
Chief Economist,
Marc Trusheim,
Visiting Scientist,
MIT Sloan School of Management
MIT Center for Biomedical Innovation
bart-Vannieuwenhuyse  andrew-ward  TimWilliams-sq
Bart Vannieuwenhuyse,
Senior Director Health Information Sciences,
Janssen Pharmaceutical Companies
of Johnson and Johnson
Andrew Ward,
Pharmaceuticals Correspondent,
Financial Times
Tim Williams,
Head of Research,
Clinical Practice Research Datalink
Geoff Wilson_Dec 31 2012 (3)  stephen-whitehead2-sq
Geoff Wilson,
HTA Task Force Leader,
Stephen Whitehead,
Chief Executive,

This conference is supported by:

 pfizer janssen oracle
health-policy-logo ibm_logo-small abpi_logo

Research Partners:

casmi cprd2 eapm
powhealth_icon_nostrapline handlemy health PMC_Logo
 Large-Color-PennMedicineLogo-small PatientsKnowBest

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.